REG - ConvaTec Group PLC - Director Declaration

ConvaTecAnnouncement

06/07/2018 09:55

RNS Number : 8501T
ConvaTec Group PLC
06 July 2018
 


Reading, United Kingdom (6 July 2018) -  Further to the announcement on 3 July 2018 of the appointment of Sten Scheibye as a Non-Executive Director of ConvaTec Group Plc, it is confirmed that there are no disclosures to be made pursuant to LR 9.6.13 in relation to the appointment of Sten Scheibye.
 
Enquiries
 
Media
 
Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226
Alastair Elwen, Finsbury                                                             +44 (0)207 251 3801
Analysts and Investors
 
John Crosse, VP Investor Relations, ConvaTec                             +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec                         +44 (0)7470 909 582
investorrelations@convatec.com
 
ConvaTec Group Plc’s LEI code is 213800LS272L4FIDOH92
 
About ConvaTec


ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNUGUMCMUPRURQ